Common stock beneficial ownership blocker, percentage.

No definition available.

Name:	amrh_CommonStockBeneficialOwnershipBlockerPercentage
Namespace Prefix:	amrh_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479

+ Details

Name:	us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Number of shares of equity interests issued or issuable to acquire entity.

+ References

+ Details

Name:	us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

+ Details

Name:	us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.

+ References

+ Details

Name:	us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	dei_LegalEntityAxis=amrh_AlphaCapitalAnstaltMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=amrh_AmalgamationAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=amrh_EnvericBiosciencesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=amrh_AmalgamationAmendmentAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=amrh_SeriesBWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=amrh_SecondAmalgamationAmendmentAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=amrh_TenderAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Tender Agreement (Details Narrative) - USD ($)	Aug. 12, 2020	May 26, 2020	May 06, 2020	Jan. 10, 2020
Alpha Capital Anstalt [Member] \| Amalgamation Agreement [Member] \| Common Stock [Member]
Aggregate purchase price				$ 3,500,000
Enveric Biosciences, Inc. [Member] \| Amalgamation Amendment Agreement [Member] \| Common Stock [Member] \| Series B Warrants [Member]
Warrants to acquire shares of common stock			8,100,000
Warrants exercise per share			$ 0.01
Enveric Biosciences, Inc. [Member] \| Second Amalgamation Amendment Agreement [Member] \| Series B Warrants [Member]
Warrants to acquire shares of common stock		8,100,000
Enveric Biosciences, Inc. [Member] \| Second Amalgamation Amendment Agreement [Member] \| Common Stock [Member]
Number of shares issued during amalgamation		3,675,035
Enveric Biosciences, Inc. [Member] \| Tender Agreement [Member]
Common stock beneficial ownership blocker, percentage	9.99%